In response to last October’s FDA Patient-Focused Drug Development Guidance public workshop, we concluded our invited comment by raising the concern that the pharmaceutical clinical trial community would be limited to innovate unless we embrace high quality mixed methods patient centered outcomes research. We are, therefore, delighted to read that the FDA is creating a […]

ISOQOL’s annual conference will be a key milestone for us at Modus this year. Not only because 5 years ago the idea of Modus Outcomes came about after a meeting in Dublin and a Guinness or two, but also because we will be presenting our research! On Wednesday afternoon (October 24), Antoine will co-lead a workshop on a […]

This month saw the XXII World Congress of the International Measurement Confederation (IMEKO), a voluntary, non-governmental federation of 42 metrological organizations from all over the world. The conference was held in Belfast, UK and hosted by the Institute of Measurement and Control with support from the National Physical Laboratory. Its theme was ‘Knowledge Through Measurement’. Excitingly for the […]

On April 9th, in downtown New York City, we hosted our third ‘Patient-centered drug development: reflections, challenges & solutions’ workshop entitled: ‘Why we need to move to modern test theory: real world examples’. Once again, our roundtable event gathered a strong group of industry, academic and clinical representatives. Our external invited speakers included Professor Peter […]

We were very happy to have Farrah Pompilus represent Modus Outcomes at the inaugural FDA PFDD public workshop as an attendee in December 2017. It is encouraging to see that the FDA will be developing four guidance documents to further ensure greater patient-focused input throughout the regulatory process. We trust that these new documents will […]

Following the success of our inaugural event in May 2017, and an overwhelming demand to host a second roundtable workshop, we were pleased to host our second invitation-only event “Patient-Centered Drug Development: Reflections, Challenges, & Solutions” on November 8th, 2017 at the Glasgow Science Center, Glasgow, Scotland. During this exclusive event we brought together strategic […]

Learn in this article how a concept-driven measurement approach addresses the many challenges of evaluating direct treatment benefit in rare diseases. Modus Outcomes’ team has developed successful concept-driven measurement solutions for sponsors in rare diseases. More specifically, we can help you: Run a tailored workshop on the lessons from the paper Apply these solutions to […]

This week is ISOQOL’s 24th Annual Conference in Philadelphia and this year is quite special for Modus Outcomes, as it will be the first year with Antoine as a member of the Board of Directors. This prestigious position is a recognition from our peers of our leadership in patient-centered outcomes research and contribution to the development […]